Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H5N1 Vaccine in Vaccine Manufacturing Workers
NCT00311649Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2005
- Primary completion
- Sep 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of inactivated influenza a vaccine A/H5N1 in Influenza A H5N1 infection (H5N1), sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2005; status: completed.
02
Drugs
inactivated influenza a vaccine A/H5N1
03
Conditions
Influenza A H5N1 infection (H5N1)
Beyond the preview
Go deeper on NCT00311649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311649.